Skip to main content
Caplight Logo









Farcast Biodynamics

Farcast Biodynamics

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://www.farcastbio.com/

Last Round

Series C

Jul 11, 2018

Total Funding Raised

$80.6M

Company Overview

Farcast Biodynamics is a biotechnology company that develops a proprietary tumor microenvironment platform to predict cancer treatment responses and accelerate drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

tumor microenvironmentTMEex vivo histoculturepredictive biosignaturesoncology drug developmentorganoidtranslational researchliquid biopsyprecision medicinedrug discoveryAI-driven analyticsmultiomicsclinical trial supportdrug screeningbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Farcast Biodynamics Comparables

Compare Farcast Biodynamics with similar companies based on industry and business-model similarity.

Farcast Biodynamics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kiyatec
86%
Xsphera Biosciences
86%
Nilogen Oncosystems
85%

Farcast Biodynamics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 11, 2018
Series B ExtensionAug 29, 2016
Series BOct 25, 2013
Series AApr 27, 2010

Key People

Founding team and executive leadership

Mohit Malhotra

Chief Executive Officer

Executive Team

Farcast Biodynamics Investors

Notable investors and investment history

Farcast Biodynamics investors
InvestorRounds
RA Capital ManagementSeries C, Series B Extension
Peak XV PartnersSeries B Extension
Northpond VenturesSeries C
Sequoia CapitalSeries C
Karnataka Information Technology Venture FundSeries A
India Innovation FundSeries B, Series A
Sands CapitalSeries C, Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 25, 2013

    $7M round led by Tata Capital Innovations Fund.

  • Apr 27, 2010

    $7M round led by Accel.

Farcast Biodynamics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Farcast Biodynamics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Farcast Biodynamics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range48
Year Founded2010
Last FundingJul 11, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?